However, some lesions are still reported as PI-RADS 4 and 5 but are biopsy-proven benign.

14 июн. 2023 г. · PI-RADS 4 lesions are considered to have a “high” likelihood of clinically-significant prostate cancer (csPCa). However, patients undergoing ...

PI-RADS 4 lesions are considered to have a “high” likelihood of clinically-significant prostate cancer (csPCa). However, patients undergoing targeted biopsy ...

25 июн. 2024 г. · Out of 11 patients with PIRADS 4 persistence, seven (63.6%) had benign biopsy results, two (18.2%) had ISUP GG 1, and two (18.2%) had >ISUP GG 1 ... Abstract · INTRODUCTION · RESULTS · DISCUSSION

Texture analysis based on PI-RADS 4/5-scored magnetic resonance images combined with machine learning to distinguish benign lesions from prostate cancer.

21 окт. 2021 г. · 15%-35% of high-risk lesions (Prostate Imaging-Reporting and Data System [PI-RADS] 4 and 5) are histologically benign.

24 окт. 2024 г. · Only 19 patients (26.4%) had persistent PI-RADS 4–5 lesions, of whom 16 underwent MRI TBx repeat biopsy. Prostate cancer (PCa) was detected in 6/16 cases (37.5 ...

1 мая 2022 г. · Consistent with literature, 37% of PIRADS 4 lesions are benign in our series. Our results suggest that men of AA race, or those with PSAD> 0.15 ...

21 окт. 2021 г. · Conclusions. Histologically benign PI-RADS 4 and 5 lesions harbor prostate cancer-associated epigenetic alterations. 1 ...